New SMC guidance for DLBCL
The Scottish Medicines Consortium recommends loncastuximab tesirine but not axicabtagene ciloleucel as treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
The Scottish Medicines Consortium recommends loncastuximab tesirine but not axicabtagene ciloleucel as treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma.
Information and support around stem cell transplants as a treatment for lymphoma.
A celebration of the diverse NHS workforce.
Dorothy Reed - giving Hodgkin lymphoma a clear diagnostic marker.
Some women at risk following chest radiotherapy for Hodgkin lymphoma.
New treatment available for relapsed or refractory diffuse large B-cell lymphoma.
There is one week left to vote for our Lymphoma Symptoms animation in this year’s awards.
Tom Kerry takes you behind the scenes of the hospital pharmacist.
Remembering Lymphoma Action in your Will is a simple way to make a huge impact.
Raising awareness of rare diseases worldwide.